Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research, clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, reversible Streptamers, or dye-conjugated pMHC multimers are distinct pMHC reagents tailored for T cell identification, traceless T cell isolation, or TCR characterization, respectively. The specific applicability of each pMHC-based reagent is made possible either through conjugation of probes or reversible multimerization in separate production processes, which is laborious, time-consuming, and prone to variability between the different types of pMHC reagents. This prohibits broad implementation of different types of pMHC reagents as a standard toolbox in routine clinical immune monitoring and immunotherapy. In this article, we describe a novel method for fast and standardized generation of any pMHC multimer reagent from a single precursor ("FLEXamer"). FLEXamers unite reversible multimerization and versatile probe conjugation through a novel double tag (Strep-tag for reversibility and Tub-tag for versatile probe conjugation). We demonstrate that FLEXamers can substitute conventional pMHC reagents in all state-of-the-art applications, considerably accelerating and standardizing production without sacrificing functional performance. Although FLEXamers significantly aid the applicability of pMHC-based reagents in routine workflows, the double tag also provides a universal tool for the investigation of transient molecular interactions in general.

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801435DOI Listing

Publication Analysis

Top Keywords

pmhc reagents
16
double tag
12
tag universal
8
pmhc multimers
8
clinical immune
8
immune monitoring
8
applicability pmhc-based
8
reversible multimerization
8
types pmhc
8
versatile probe
8

Similar Publications

Article Synopsis
  • * Cholesterol is crucial for the stability of the TCR-CD3 complex, and altered mutations impacting TCR-CD3 interactions hinder effective signaling by maintaining necessary subunit fluidity.
  • * The TCR-CD3 complex exhibits minimal movement when interacting with activating antibodies, indicating that there are no distinct 'inactive-active' states at the extracellular level, which is significant for understanding TCR signaling and potential therapeutic applications.
View Article and Find Full Text PDF

T cell receptor (TCR) clustering and formation of an immune synapse are crucial for TCR signaling. However, limited information is available about these dynamic assemblies and their connection to transmembrane signaling. In this work, TCR clustering is controlled via plug-and-play nanotools based on an engineered irreversible conjugation pair and a peptide-loaded major histocompatibility complex (pMHC) molecule to compare receptor assembly in a ligand (pMHC)-induced or ligand-independent manner.

View Article and Find Full Text PDF

Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.

J Immunol

April 2024

Molecular Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

mAbs to MHC class I (MHC-I) molecules have proved to be crucial reagents for tissue typing and fundamental studies of immune recognition. To augment our understanding of epitopic sites seen by a set of anti-MHC-I mAb, we determined X-ray crystal structures of four complexes of anti-MHC-I Fabs bound to peptide/MHC-I/β2-microglobulin (pMHC-I). An anti-H2-Dd mAb, two anti-MHC-I α3 domain mAbs, and an anti-β2-microglobulin mAb bind pMHC-I at sites consistent with earlier mutational and functional experiments, and the structures explain allelomorph specificity.

View Article and Find Full Text PDF

Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction.

bioRxiv

December 2023

Molecular Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD, 20892-1892.

Monoclonal antibodies (mAb) to major histocompatibility complex class I (MHC-I) molecules have proved to be crucial reagents for tissue typing and fundamental studies of immune recognition. To augment our understanding of epitopic sites seen by a set of anti-MHC-I mAb, we determined X-ray crystal structures of four complexes of anti-MHC-I antigen-binding fragments (Fab) bound to peptide/MHC-I/βm (pMHC-I). An anti-H2-D mAb, two anti-MHC-I α3 domain mAb, and an anti-β-microglobulin (βm) mAb bind pMHC-I at sites consistent with earlier mutational and functional experiments, and the structures explain allelomorph specificity.

View Article and Find Full Text PDF
Article Synopsis
  • Novel single-cell technologies can efficiently pair T cell receptor (TCR) sequences with their corresponding peptide-MHC recognition motifs using DNA barcode-labeled reagents.
  • The analysis of single-cell sequencing data faces challenges such as dropout and noise, which require careful handling in processing.
  • The newly proposed method, ITRAP, filters out these artifacts to produce reliable TCR-pMHC sequence data, successfully identifying 1494 high-confidence TCR-pMHC pairs from 4135 single cells in a study involving 16 healthy donors.
View Article and Find Full Text PDF